The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 31, 2023

Filed:

Dec. 18, 2020
Applicant:

A & G Pharmaceutical, Inc., Columbia, MD (US);

Inventor:

Jun Hayashi, Columbia, MD (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61P 1/00 (2006.01); A61P 3/00 (2006.01); A61P 3/10 (2006.01); A61P 5/14 (2006.01); A61P 13/12 (2006.01); A61P 37/00 (2006.01); A61P 25/00 (2006.01); A61P 29/00 (2006.01); A61K 31/455 (2006.01); A61K 31/502 (2006.01); A61K 31/609 (2006.01);
U.S. Cl.
CPC ...
A61K 39/0008 (2013.01); A61K 31/455 (2013.01); A61K 31/502 (2013.01); A61K 31/609 (2013.01); A61P 1/00 (2018.01); A61P 3/00 (2018.01); A61P 3/10 (2018.01); A61P 5/14 (2018.01); A61P 13/12 (2018.01); A61P 25/00 (2018.01); A61P 29/00 (2018.01); A61P 37/00 (2018.01);
Abstract

The present invention provides materials and methods for making a subject non-responsive to an antigen. Methods of the invention may comprise contacting the subject with the antigen and a compound that induces anergy. In some embodiments, the antigen may be an autoimmune antigen, examples of which include, but are not limited to acetylcholine receptor for myasthenia gravis, glutamic acid decarboxylase for type I diabetes mellitus and rheumatoid factor in rheumatoid arthritis. In some embodiments, the present invention provides a method of transplanting an organ, tissue, or cells into a subject (e.g. a mammal such as a human).


Find Patent Forward Citations

Hayashi, Jun. (2023). Materials and methods for the development of an antigen-specific immune non-responsiveness state (U.S. Patent No. 11801287). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11801287

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…